These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 27365371
1. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus. Santos FM, Telles RW, Lanna CC, Teixeira AL, Miranda AS, Rocha NP, Ribeiro AL. Lupus; 2017 Jan; 26(1):10-16. PubMed ID: 27365371 [Abstract] [Full Text] [Related]
2. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegård J. Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473 [Abstract] [Full Text] [Related]
5. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. Patel M, Oni L, Midgley A, Smith E, Tullus K, Marks SD, Jones CA, Pilkington C, Beresford MW. Lupus; 2016 Aug; 25(9):1040-4. PubMed ID: 26854079 [Abstract] [Full Text] [Related]
6. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA, El-Gendi HI, Ahmed HH. Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [Abstract] [Full Text] [Related]
8. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis. Owczarek D, Cibor D, Głowacki MK, Cieśla A, Mach P. Pol Arch Med Wewn; 2012 Feb; 122(12):616-23. PubMed ID: 23160117 [Abstract] [Full Text] [Related]
9. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure. Denollet J, Vrints CJ, Conraads VM. Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948 [Abstract] [Full Text] [Related]
10. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Safranow K, Dziedziejko V, Rzeuski R, Czyzycka E, Wojtarowicz A, Bińczak-Kuleta A, Jakubowska K, Olszewska M, Ciechanowicz A, Kornacewicz-Jach Z, Machaliński B, Pawlik A, Chlubek D. Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893 [Abstract] [Full Text] [Related]
11. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder. Doganavsargil-Baysal O, Cinemre B, Aksoy UM, Akbas H, Metin O, Fettahoglu C, Gokmen Z, Davran F. Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748 [Abstract] [Full Text] [Related]
12. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease. Turan B, Pfister K, Diener PA, Hell M, Möller B, Boyvat A, Ergin S, Villiger PM. Scand J Rheumatol; 2008 Mar; 37(2):135-41. PubMed ID: 18415772 [Abstract] [Full Text] [Related]
13. The influence of chosen adipocytokines on blood pressure values in patients with metabolic syndrome. Musialik K. Kardiol Pol; 2012 Mar; 70(12):1237-42. PubMed ID: 23264241 [Abstract] [Full Text] [Related]
14. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3. Tziakas D, Chalikias G, Parissis JT, Hatzinikolaou H, Stakos D, Papadopoulou E, Kortsaris A, Hatseras D. Eur Cytokine Netw; 2004 Mar; 15(3):231-9. PubMed ID: 15542448 [Abstract] [Full Text] [Related]
15. TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Svenungsson E, Fei GZ, Jensen-Urstad K, de Faire U, Hamsten A, Frostegard J. Lupus; 2003 Mar; 12(6):454-61. PubMed ID: 12873047 [Abstract] [Full Text] [Related]
16. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC. Clin Rheumatol; 1999 Mar; 18(1):17-22. PubMed ID: 10088943 [Abstract] [Full Text] [Related]
18. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease. Wakiya R, Ueeda K, Shimada H, Nakashima S, Kameda T, Miyatake N, Kato M, Miyagi T, Sugihara K, Mizusaki M, Mino R, Kadowaki N, Dobashi H. Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246 [Abstract] [Full Text] [Related]
19. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease]. Olszanecka-Glinianowicz M, Waluszek-Kończakowska I, Zahorska-Markiewicz B, Janowska J. Endokrynol Pol; 2005 Nov; 56(2):174-8. PubMed ID: 16335686 [Abstract] [Full Text] [Related]
20. Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia. Noto C, Gadelha A, Belangero SI, Spindola LM, Rocha NP, de Miranda AS, Teixeira AL, Cardoso Smith MA, de Jesus Mari J, Bressan RA, Brietzke E. J Psychiatr Res; 2013 Apr; 47(4):467-71. PubMed ID: 23360651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]